Avinger Enrolls First 50 Patients in INSIGHT Clinical Trial

Stock Information for Avinger Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Avinger Inc.

Avinger Reports Fourth Quarter and Full Year 2023 Results
Avinger to Announce Full Year 2023 Results on March 20, 2024
Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge
Avinger Reports Third Quarter 2023 Results
Avinger to Announce Third Quarter 2023 Results on October 26
Avinger Raises $5.3 Million via At-The-Market Facility
Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device
Avinger Announces Presentations by Key Opinion Leaders at AMP (The Amputation Prevention Symposium) 2023

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.